-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VWPqxGfzvZH1PzPRH52UNuqjBaJSgGSDxaP5ZGfbK9TseGRfdgTzbgzgZZf0/XQZ MkOjRFCHAE+NM1VK6y3ppQ== 0001362310-09-007527.txt : 20090515 0001362310-09-007527.hdr.sgml : 20090515 20090515060116 ACCESSION NUMBER: 0001362310-09-007527 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090515 DATE AS OF CHANGE: 20090515 GROUP MEMBERS: LINDEN CAPITAL LP GROUP MEMBERS: LINDEN GP LLC GROUP MEMBERS: SIU MIN WONG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VERENIUM CORP CENTRAL INDEX KEY: 0001049210 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 223297375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60329 FILM NUMBER: 09828746 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 674 5300 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: DIVERSA CORP DATE OF NAME CHANGE: 19991201 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Linden Capital L.P. CENTRAL INDEX KEY: 0001349339 IRS NUMBER: 980430338 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 18 CHURCH STREET, SKANDIA HOUSE CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-294-3202 MAIL ADDRESS: STREET 1: 18 CHURCH STREET, SKANDIA HOUSE CITY: HAMILTON STATE: D0 ZIP: HM11 SC 13G 1 c85532sc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.       )*

Verenium Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
92340P100
(CUSIP Number)
May 6, 2009
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Linden Capital LP
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Bermuda
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   5,371,625
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    5,371,625
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  5,371,625
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

2


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Linden GP LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   5,371,625
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    5,371,625
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  5,371,625
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

3


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Siu Min Wong
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  China
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   5,371,625
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    5,371,625
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  5,371,625
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN, HC

4


 

ITEM 1(a). Name of Issuer:
Verenium Corporation (the “Issuer”).
Item 1(b). Address of Issuer’s Principal Executive Offices:
55 Cambridge Parkway
Cambridge, Massachusetts 02142
Item 2(a). Name of Persons Filing:
The names of the persons filing this statement on Schedule 13G are: Linden Capital LP, a Bermuda limited partnership (“Linden Capital”), Linden GP LLC, a Delaware limited liability company (“Linden GP”), and Siu Min Wong (“Mr. Wong,” and collectively, the “Reporting Persons”). Linden GP is the general partner of Linden Capital, and Mr. Wong is the managing member of Linden GP. Therefore, Linden GP and Mr. Wong may each be deemed to beneficially own the shares of Common Stock (as defined below) owned by Linden Capital.
Item 2(b). Address of Principal Business Office or, if None, Residence:
The principal business address for Linden Capital is Ingham & Wilkinson Building, 129 Front Street, Hamilton HM 12, Bermuda.
The principal business address for each of Linden GP and Mr. Wong is 590 Madison Avenue, 15th Floor, New York, New York 10022.
Item 2(c). Citizenship:
Linden Capital is a Bermuda limited partnership.
Linden GP is a Delaware limited liability company.
Mr. Wong is a citizen of China.
Item 2(d). Title of Class of Securities
Common Stock, $.001 par value per share (the “Common Stock”).
Item 2(e). CUSIP Number: 92340P100
Item 3.   If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: Not applicable.
  (a)   o   Broker or dealer registered under Section 15 of the Exchange Act.
 
  (b)   o   Bank as defined in Section 3(a)(6) of the Exchange Act.
 
  (c)   o   Insurance company defined in Section 3(a)(19) of the Exchange Act.
 
  (d)   o   Investment company registered under Section 8 of the Investment Company Act.

 

5


 

  (e)   o   An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
 
  (f)   o   An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
 
  (g)   o   A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
 
  (h)   o   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
 
  (i)   o   A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
 
  (j)   o   Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
  (a)   Amount beneficially owned:
 
      The Reporting Persons collectively beneficially own 4,887,867 shares of Common Stock and warrants to purchase 483,758 shares of Common Stock, or an aggregate of 5,371,625 shares of Common Stock.
 
  (b)   Percent of class:
 
      The Reporting Persons have beneficial ownership of shares constituting 6.5% of all of the outstanding shares of Common Stock.
 
  (c)   Number of shares as to which such person has:
  (i)   Sole power to vote or to direct the vote
      Not applicable.
  (ii)   Shared power to vote or to direct the vote
      Linden Capital, Linden GP and Mr. Wong have shared power to vote or direct the vote of the 5,371,625 shares of Common Stock held by Linden Capital.
  (iii)   Sole power to dispose or to direct the disposition of
      Not applicable.
  (iv)   Shared power to dispose or to direct the disposition of
      Linden Capital, Linden GP and Mr. Wong have shared power to dispose or direct the disposition of the 5,371,625 shares of Common Stock held by Linden Capital.

 

6


 

Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
See Exhibit B attached hereto.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

7


 

SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
Dated: May 15, 2009
         
LINDEN CAPITAL L.P.
 
   
By:   Linden GP LLC, general partner
 
   
By:   /S/ Siu Min Wong      
  Siu Min Wong,     
  Managing Member     
 
LINDEN GP LLC
 
   
By:   /S/ Siu Min Wong      
  Siu Min Wong,     
  Managing Member     
 
     
/S/ Siu Min Wong      
SIU MIN WONG     
     

 

8


 

         
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Verenium Corporation dated May 15, 2009 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: May 15, 2009
         
LINDEN CAPITAL L.P.
 
   
By:   Linden GP LLC, general partner
 
   
By:   /S/ Siu Min Wong      
  Siu Min Wong,     
  Managing Member     
 
LINDEN GP LLC
 
   
By:   /S/ Siu Min Wong      
  Siu Min Wong,     
  Managing Member     
 
     
/S/ Siu Min Wong      
SIU MIN WONG     
     
 

 

9


 

EXHIBIT B
IDENTIFICATION OF MEMBERS OF THE GROUP
Linden Capital L.P.
Linden GP LLC
Siu Min Wong

 

10

-----END PRIVACY-ENHANCED MESSAGE-----